Identification of selectivity-determining residues in cytochrome P450 monooxygenases: A systematic analysis of the substrate recognition site 5

Proteins: Structure, Function and Bioinformatics

Volumn 74, Issue 4, 2009, Pages 1028-1035

  Seifert, Alexander ^a   Pleiss, Jürgen ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

Author keywords

Regioselectivity; SRS 5; Structure and sequence analysis; Substrate specificity

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 OXYGENASE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE; HEME;

AMINO ACID SEQUENCE; ARTICLE; BACTERIAL STRAIN; CRYSTAL STRUCTURE; ENZYME ANALYSIS; HYDROPHOBICITY; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN MOTIF; BINDING SITE; CHEMISTRY; ENZYME SPECIFICITY; METABOLISM; NUCLEOTIDE SEQUENCE; PROTEIN DATABASE;

AMINO ACID MOTIFS; BINDING SITES; CONSERVED SEQUENCE; CYTOCHROME P-450 ENZYME SYSTEM; DATABASES, PROTEIN; HEME; SUBSTRATE SPECIFICITY;

EID: 61449134084     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.22242     Document Type: Article

References (31)

1. Urlacher VB, Eiben S. Cytochrome P450 monooxygenases: perspectives for synthetic application. Trends Biotechnol 2006;24:324-330.
2. Anzenbacher P, Anzenbacherova E. Cytochromes P450 and metabolism of xenobiotics. Cell Mol Life Sci 2001;58:737-747.
3. Smith DA, Ackland MJ, Jones BC. Properties of cytochrome P450 isoenzymes and their substrates. Part 1: active site characteristics. Drug Discov Today 1997;2:406-414.
4. Fischer M, Knoll M, Sirim D, Wagner F, Funke S, Pleiss J. The Cytochrome P450 Engineering Database: a navigation and prediction tool for the cytochrome P450 protein family. Bioinformatics 2007;23:2015-2017.
5. Vidakovic M, Sligar SG, Li H, Poulos TL. Understanding the role of the essential Asp251 in cytochrome p450cam using site-directed mutagenesis, crystallography, and kinetic solvent isotope effect. Biochemistry 1998;37:9211-9219.
6. Ravichandran KG, Boddupalli SS, Hasermann CA, Peterson JA, Deisenhofer J. Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. Science 1993;261:731-736.
7. Hasemann CA, Kurumbail RG, Boddupalli SS, Peterson JA, Deisenhofer J. Structure and function of cytochromes-P450 - a comparative-analysis of 3 crystal-structures. Structure 1995;3:41-62.
8. Rupasinghe S, Schuler MA, Kagawa N, Yuan H, Lei L, Zhao B, Kelly SL, Waterman MR, Lamb DC. The cytochrome P450 gene family CYP157 does not contain EXXR in the K-helix reducing the absolute conserved P450 residues to a single cysteine. FEBS Lett 2006;580:6338-6342.
9. Oprea TI, Hummer G, Garcia AE. Identification of a functional water channel in cytochrome P450 enzymes. Proc Natl Acad Sci USA 1997;94:2133-2138.
10. Mestres J. Structure conservation in cytochromes P450. Proteins 2005;58:596-609.
11. Bell SG, Chen X, Sowden RJ, Xu F, Williams JN, Wong LL, Rao Z. Molecular recognition in (+)-alpha-pinene oxidation by cytochrome P450cam. J Am Chem Soc 2003;125:705-714.
12. Seifert A, Tatzel S, Schmid RD, Pleiss J. Multiple molecular dynamics simulations of human p450 monooxygenase CYP2C9: the molecular basis of substrate binding and regioselectivity toward warfarin. Proteins 2006;64:147-155.
13. Fruetel JA, Mackman RL, Peterson JA, Ortiz de Montellano PR. Relationship of active site topology to substrate specificity for cytochrome P450terp (CYP108). J Biol Chem 1994;269:28815-28821.
14. Gotoh O. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J Biol Chem 1992;267:83-90.
15. Born SL, John GH, Harlow GR, Halpert JR. Characterization of the progesterone 21-hydroxylase activity of canine cytochrome P450 PBD-2/P450 2B11 through reconstitution, heterologous expression, and site-directed mutagenesis. Drug Metab Dispos 1995; 23:702-707.
16. Lentz O, Feenstra A, Habicher T, Hauer B, Schmid RD, Urlacher VB. Altering the regioselectivity of cytochrome P450 CYP102A3 of Bacillus subtilis by using a new versatile assay system. Chembiochem 2006;7:345-350.
17. Liu J, Ericksen SS, Sivaneri M, Besspiata D, Fisher CW, Szklarz GD. The effect of reciprocal active site mutations in human cytochromes P450 1A1 and 1A2 on alkoxyresorufin metabolism. Arch Biochem Biophys 2004;424:33-43.
18. Meinhold P, Peters MW, Hartwick A, Hernandez AR, Arnold FH. Engineering cytochrome P450BM3 for terminal alkane hydroxylation. Adv Synth Catal 2006;348:763-772.
19. Urlacher VB, Makhsumkhanov A, Schmid RD. Biotransformation of beta-ionone by engineered cytochrome P450 BM-3. Appl Microbiol Biotechnol 2006;70:53-59.
20. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
21. DeLano WL. The PyMOL molecular graphics system. San Carlos, CA: DeLano Scientific; 2002.
22. Anderson DE, Becktel WJ, Dahlquist FW. Ph-induced denaturation of proteins - a single salt bridge contributes 3-5 kcal mol to the free-energy of folding of T4-lysozyme. Biochemistry 1990;29:2403-2408.
23. Inagaki F, Kawano Y, Shimada I, Takahashi K, Miyazawa T. Nuclear magnetic-resonance study on the micro-environments of histidine-residues of ribonuclease-T1 and carboxymethylated ribonuclease-T1. J Biochem 1981;89:1185-1195.
24. He YA, He YQ, Szklarz GD, Halpert JR. Identification of three key residues in substrate recognition site 5 of human cytochrome P450 3A4 by cassette and site-directed mutagenesis. Biochemistry 1997;36:8831-8839.
25. Keizers PH, Lussenburg BM, de Graaf C, Mentink LM, Vermeulen NP, Commandeur JN. Influence of phenylalanine 120 on cytochrome P450 2D6 catalytic selectivity and regiospecificity: crucial role in 7-methoxy-4-(aminomethyl)- coumarin metabolism. Biochem Pharmacol 2004;68:2263-2271.
26. Melet A, Assrir N, Jean P, Pilar Lopez-Garcia M, Marques-Soares C, Jaouen M, Dansette PM, Sari MA, Mansuy D. Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid. Arch Biochem Biophys 2003;409:80-91.
27. Sherman DH, Li S, Yermalitskaya LV, Kim Y, Smith JA, Waterman MR, Podust LM. The structural basis for substrate anchoring, active site selectivity, and product formation by P450 PikC from Streptomyces venezuelae. J Biol Chem 2006;281:26289-26297.
28. Clark JP, Miles CS, Mowat CG, Walkinshaw MD, Reid GA, Daff SN, Chapman SK. The role of Thr268 and Phe393 in cytochrome P450 BM3. J Inorg Biochem 2006;100:1075-1090.
29. Macarthur MW, Thornton JM. Influence of proline residues on protein conformation. J Mol Biol 1991;218:397-412.
30. Kerdpin O, Elliot DJ, Boye SL, Birkett DJ, Yoovathaworn K, Miners JO. Differential contribution of active site residues in substrate recognition sites 1 and 5 to cytochrome P450 2C8 substrate selectivity and regioselectivity. Biochemistry 2004;43:7834-7842.
31. Schalk M, Croteau R. A single amino acid substitution (F363I) converts the regiochemistry of the spearmint (-)-limonene hydroxylase from a C6- to a C3-hydroxylase. Proc Natl Acad Sci USA 2000;97:11948-11953.